Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-05-20

Clinical Trial Update: The Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial studying the effects of isoflavone and estrogen on sex response in climacteric women with postmenopausal symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estrogen (Estrogen)
  • Isoflavone (isoflavone)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Postmenopausal Symptoms | Phase 3 | Status: UNKNOWN